Christopher H. Lindstrom

Nutter advised Cali’flour Foods, the developer and manufacturer of low-carb, gluten-free cauliflower products, in a Series A financing round led by Sunrise Strategic Partners, with participation from CircleUp Growth Partners.

Nutter filed a successful amicus brief on behalf of the Greater Boston Chamber of Commerce in Calixto, et al. v. Coughlin, et al. that warned against expanding the Massachusetts Wage Act beyond earned wages. According to the brief authors, doing so would have created uncertainty for employers and have had a detrimental effect on distressed businesses.

Nutter represented a class of insurance companies in RICO litigation filed against one of their competitors.

Defending a biotechnology company against claims of breach of contract and licensing fees relating to the purchase of intellectual property. Settled on the eve of an arbitration hearing on terms favorable to the client.

Obtaining summary judgment in favor of a medical device company and against a former employee who brought claims sounding in disability discrimination, interference with contractual relations, and breach of a stock options agreement.

Representing an equipment leasing company against claims of breach of contract and tortious interference claims which the court dismissed before trial.

Representing several employers, including manufacturers, retailers, food service distributors, and medical device manufacturers, in the defense of employee discrimination claims before the Massachusetts Commission Against Discrimination.

Representing a professional services firm against RICO claims, claims which were dismissed by a federal court in a ruling that was affirmed at the appellate level.

Representing individual defendants as part of trial team against claims of breach of fiduciary duty and freeze-out in close corporation. Following a five day hearing, the arbitrator ruled in favor of the clients on all claims.

Pursuing and defending against claims of breaches of non-competition and non-disclosure agreements for a diverse group of employers across the country.

Nutter defended a Fortune 100 insurance company in multistate litigation arising out of the hiring of agents from a competitor, including claims relating to non-competes, breach of contract, and tortious interference.

Nutter represented and counseled a Fortune 100 medical device company in non-compete, non-solicit, and trade secret strategy and litigation throughout the country.

Nutter represented and counseled a Fortune 100 medical device company in non-compete, non-solicit, and trade secret strategy and litigation throughout the country.

Nutter represented a health insurance plan in a qui tam lawsuit alleging billing improprieties, and prevailed at motion to dismiss stage.

Nutter represented a major medical device manufacturer in defending multiple whistleblower claims brought by former employees in several jurisdictions.

Nutter represented a medical device manufacturer in multiyear non-compete litigation involving significant sales representatives who made multiple moves between competitors.

Nutter represented a pharmaceutical company in connection with its hiring of a senior researcher. We navigated the non-compete and trade secret issues and obtained a favorable settlement after expedited discovery.

Nutter represented a laboratory in qui tam litigation alleging fraudulent billing practices, and secured a key court opinion favorable to the entire industry.

Nutter served as legal counsel to Innovation Associates, the market-leading provider of high-volume pharmacy automation technology and software solutions to the retail, hospital, government, and mail order pharmacy markets, in connection with a consortium of investors led by Greg Wasson, the former Walgreens Boots Alliance CEO, acquiring a majority stake to scale the business and enhance its pharmacy automation offerings.

Nutter represented a wealth management group in pursuing non-compete and non-solicitation claims against a Fortune 100 company and three former employees. We obtained a favorable pre-litigation settlement.

Nutter represented certain senior management in connection with the sale of ZappRx to Allscripts.